Search

Your search keyword '"Amyloidogenic Proteins ultrastructure"' showing total 39 results

Search Constraints

Start Over You searched for: Descriptor "Amyloidogenic Proteins ultrastructure" Remove constraint Descriptor: "Amyloidogenic Proteins ultrastructure"
39 results on '"Amyloidogenic Proteins ultrastructure"'

Search Results

1. Amyloid-like aggregating proteins cause lysosomal defects in neurons via gain-of-function toxicity.

2. Heat treatment of soluble proteins isolated from human cataract lens leads to the formation of non-fibrillar amyloid-like protein aggregates.

3. Is It Possible to Create Antimicrobial Peptides Based on the Amyloidogenic Sequence of Ribosomal S1 Protein of P. aeruginosa ?

4. Amyloid-type Protein Aggregation and Prion-like Properties of Amyloids.

5. Full-length TDP-43 and its C-terminal domain form filaments in vitro having non-amyloid properties.

6. On the Protein Fibrillation Pathway: Oligomer Intermediates Detection Using ATR-FTIR Spectroscopy.

7. Single Molecule Characterization of Amyloid Oligomers.

8. Embryonic cuticle from artemia cyst shell displays amyloid-like characteristics and nontoxicity after oral consumption.

9. Molecular mechanism of amyloidogenic mutations in hypervariable regions of antibody light chains.

10. Predicted aggregation-prone region (APR) in βB1-crystallin forms the amyloid-like structure and induces aggregation of soluble proteins isolated from human cataractous eye lens.

11. Gallic acid oxidation products alter the formation pathway of insulin amyloid fibrils.

12. Hydroxyapatite Formation Coexists with Amyloid-like Self-Assembly of Human Amelogenin.

13. A near-infrared fluorescent probe quinaldine red lights up the β-sheet structure of amyloid proteins in mouse brain.

14. hnRNPDL Phase Separation Is Regulated by Alternative Splicing and Disease-Causing Mutations Accelerate Its Aggregation.

15. Amyloid-Forming Segment Induces Aggregation of FUS-LC Domain from Phase Separation Modulated by Site-Specific Phosphorylation.

16. N-Terminal Ubiquitination of Amyloidogenic Proteins Triggers Removal of Their Oligomers by the Proteasome Holoenzyme.

17. Structural Heterogeneity in the Preamyloid Oligomers of β-2-Microglobulin.

18. Examination of Adsorption Orientation of Amyloidogenic Peptides Over Nano-Gold Colloidal Particle Surfaces.

19. Inhibition of amyloid fibrillation of apo-carbonic anhydrase by flavonoid compounds.

20. Large-scale all-atom molecular dynamics alanine-scanning of IAPP octapeptides provides insights into the molecular determinants of amyloidogenicity.

21. Effective suppression of the modified PHF6 peptide/1N4R Tau amyloid aggregation by intact curcumin, not its degradation products: Another evidence for the pigment as preventive/therapeutic "functional food".

22. The protofilament architecture of a de novo designed coiled coil-based amyloidogenic peptide.

23. Revolutionizing Our Understanding of Amyloidogenic Proteins by Cryo-Electron Microscopy.

24. Amyloid-like aggregation of designer bolaamphiphilic peptides: Effect of hydrophobic section and hydrophilic heads.

25. Glycation induced conformational alterations in caprine brain cystatin (CBC) leads to aggregation via passage through a partially folded state.

26. Resolving the Atomistic Modes of Anle138b Inhibitory Action on Peptide Oligomer Formation.

27. Real-Time Observation of the Interaction between Thioflavin T and an Amyloid Protein by Using High-Sensitivity Rheo-NMR.

28. Production of Monoclonal Antibodies to Pathologic β-sheet Oligomeric Conformers in Neurodegenerative Diseases.

29. Heparin and Methionine Oxidation Promote the Formation of Apolipoprotein A-I Amyloid Comprising α-Helical and β-Sheet Structures.

30. Insulin and Lispro Insulin: What is Common and Different in their Behavior?

31. Structural Characterization of Highly Flexible Proteins by Small-Angle Scattering.

32. Structural model of amyloid fibrils for amyloidogenic peptide from Bgl2p-glucantransferase of S. cerevisiae cell wall and its modifying analog. New morphology of amyloid fibrils.

33. New insights into in vitro amyloidogenic properties of human serum albumin suggest considerations for therapeutic precautions.

34. A simulated intermediate state for folding and aggregation provides insights into ΔN6 β2-microglobulin amyloidogenic behavior.

35. Direct observation of amyloid nucleation under nanomechanical stretching.

36. The effect of β2-α2 loop mutation on amyloidogenic properties of the prion protein.

37. Molecular mechanism of surface-assisted epitaxial self-assembly of amyloid-like peptides.

38. Unzipping a functional microbial amyloid.

39. Wet-spinning of amyloid protein nanofibers into multifunctional high-performance biofibers.

Catalog

Books, media, physical & digital resources